Grzegorz Stasilojc

4PUBLICATIONS
13CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jan 11, 2024
The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab.

Alicja Kuźniewska, Alan Majeranowski, Sara Henry

|May 14, 2022
The Cooperative Anti-Neoplastic Activity of Polyphenolic Phytochemicals on Human T-Cell Acute Lymphoblastic Leukemia Cell Line MOLT-4 In Vitro.

Patrycja Koszałka, Grzegorz Stasiłojć, Natalia Miękus-Purwin

|Mar 10, 2022
In Silico Designed Gain-of-Function Variants of Complement C2 Support Cytocidal Activity of Anticancer Monoclonal Antibodies.

Aleksandra Urban, Alan Majeranowski, Grzegorz Stasiłojć

|Apr 19, 2019
Clinical and Biological Significance of ESR1 Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients.

Anna Nagel, Jolanta Szade, Mariola Iliszko

Pageof 1

Frequent Collaborators

2 joint publications

Patrycja Koszałka

2 joint publications

Marcin Okrój

1 joint publications

Anna Nagel

1 joint publications

Jaroslaw Skokowski